検索キーワード： バイオテクノロジー

Join journalist Barry Werth as he pulls back the curtain on Vertex, a start-up pharmaceutical company, and witness firsthand the intense drama being played out in the pioneering and hugely profitable field of drug research. Founded by Joshua Boger, a dynamic Harvard- and Merck-trained scientific whiz kid, Vertex is dedicated to designing - atom by atom - both a new life-saving immunosuppressant drug and a drug to combat the virus that causes AIDS.

Once, we humans could only observe evolution. Suddenly, we had conquered it. And yet, in Life as We Made It, evolutionary biologist Beth Shapiro argues that - despite how amazing our new technologies are - our ability to alter the course of evolution isn’t new. What is new is that where once we shaped evolution through brute force, we can now do it as artisans. That power comes not a moment too soon. If we are going to survive in the next few centuries, we must revise the book of life.

In the fall of 1980, Genentech, Inc., a little-known California genetic engineering company, became the overnight darling of Wall Street, raising over $38 million in its initial public stock offering. Lacking marketed products or substantial profit, the firm nonetheless saw its share price escalate from $35 to $89 in the first few minutes of trading. Coming at a time of economic recession and declining technological competitiveness in the United States, the event ignited a period of speculative frenzy over biotechnology.

Nobody thought it was possible. In mid-January 2020, Ugur Sahin told Özlem Türeci, his wife and decades-long research partner, that a vaccine against what would soon be known as COVID-19 could be developed and safely injected into the arms of millions before the end of the year. The Vaccine draws back the curtain on one of the most important medical breakthroughs of our age.

This audiobook, Tomorrow's Medicine, looks at some of the more fascinating areas where technology that could transform health is being developed, including cybernetics, regenerative medicine, nanotechnology, and genetically tailored treatments. Although many of these advances may not be ready to treat humans for many years, some of them may someday profoundly change - and extend - our lives. As exciting as the possibilities are to extend both the length and quality of life, immortality - or at least agelessness - may be forever out of our reach.

From a leading futurist and OneShared.World founder, a "brilliant" book that explores how artificial intelligence and other revolutionary technologies are transforming our lives–and our future (Sanjay Gupta). New technologies have the potential to improve our health, feed billions of people...

Have you ever considered how short life really is? If you could buy a ticket to have a chance to see and be a part of the future, would you reserve your seat right away? Do you ever question traditional ideas about life and death, or ponder the afterlife? The Affordable Immortal empowers you to do something now in order to take advantage of Cryonics and future technology. Within a few generations, death may be optional. You have, in your hands, a ticket to a time machine, which could offer you an unimaginable life-extension odyssey!

The pharmaceutical drug discovery and development cycle is long and complex. This audiobook provides a concise overview of the whole process and offers insights into working in the pharmaceutical industry. It is ideal for individuals who are thinking about a career in this industry, as well as those who want to gain a general understanding of pharmaceutical drug discovery and development.

Contemporary Issues: Science, Africa, and More attends to very sensitive and contemporary issues pertaining to biotechnology such as human cloning and genetic engineering. It also comprises such areas as affirmative action, one's right to abortion, one's right to sexual choice(s), questions relating to whether Dr. Martin Luther King Jr. was a hero or not, and other similar but controversial issues. In addition, there are topics included in Contemporary Issues relating to matters of ethnicity, culture, and development, in particular as they impact Africa.

Pandemics have killed at least a half billion people over the past two millennia. Today a new plague, COVID-19, is stalking humanity. But in the age of biotechnology, humanity is no longer defenseless. Biotechnology in the Time of COVID-19 is a collection of stories about the biotechnology industry - its purpose, its people and how it has risen to battle the COVID-19 virus - told by 47 leaders of that industry in their own words.

Life on earth is facing unprecedented challenges from global warming, war, and mass extinctions. The plight of seeds is a less visible but no less fundamental threat to our survival. Seeds are at the heart of the planet's life-support systems. Their power to regenerate and adapt are essential to...

From the Siberian permafrost to balmy California, scientists across the globe are working to resurrect all kinds of extinct animals, from ones that just left us to those that have been gone for many thousands of years. Their tools in this hunt are both fossils and cutting-edge genetic technologies. Some of these scientists are driven by sheer curiosity; others view the lost species as a powerful weapon in the fight to preserve rapidly changing ecosystems. It seems certain that these animals will walk the earth again, but what world will that give us? And is any of this a good idea?

In the face of rapid medical advances in our world, bioethics is a serious concern for many in our society - Christians and non-Christians alike. Here, Gilbert Meilaender, professor of theological ethics at Valparaiso University in Indiana, contends that it is imperative for Christians to think consciously about bioethical issues as Christians if they are not to risk losing their Christian identity.

Since the birth of civilization, human beings have manipulated other life-forms. We have selectively bred plants and animals for thousands of years to maximize agricultural production and cater to our tastes in pets. The observation of the creation of artificial animal and plant variants was a key stimulant for Charles Darwin's theory of evolution. The ability to directly engineer the genomes of organisms first became possible in the 1970s, when the gene for human insulin was introduced into bacteria.

Could extinct species, like mammoths and passenger pigeons, be brought back to life? The science says yes. In How to Clone a Mammoth, Beth Shapiro, evolutionary biologist and pioneer in "ancient DNA" research, walks listeners through the astonishing and controversial process of de-extinction.

A panoramic overview of biotechnologies that can endlessly boost human capabilities and the drastic changes these "superhuman" traits could trigger. Biotechnology is moving fast. In the coming decades, advanced pharmaceuticals, bioelectronics, and genetic interventions will be used not only to heal the sick but to boost human physical and mental performance to unprecedented levels.

A shocking expose of the reckless proliferation of bioweapon research and development facilities across the U.S. - and the threat this poses to everyday Americans. Battling a new generation of corporate giants and uncovering threats right in our own backyard, Kenneth King’s Germs Gone Wild reveals the massive expansion of America’s biodefense research labs and the culture of deception surrounding hundreds of facilities that have opened since 9/11.

It's the ultimate technology: nanotechnology - the attempt to build ordinary objects from the atoms up, molecule by molecule. So named because its building blocks are the smallest pieces of matter, nanotechnology will give us complete control over the structure of matter, allowing us to build any substance or structure permitted by the Laws of Nature. Placing atoms as if they were bricks, nano-machines could turn grass clippings into prime sirloins - directly, without cows.

Our health care system is crippled by desperate efforts to prevent the inevitable. A third of the national Medicare budget - nearly $175 billion - is spent on the final year of life, and a third of that amount on the final month, often on expensive (and futile) treatments. Such efforts betray a fundamental flaw in how we think about healthcare: we squander resources on hopeless situations, instead of using them to actually improve health.

From foolproof lie detectors to sure-fire investment strategies to super-enhanced religious and aesthetic experiences, the insights and revelations within The Neuro Revolution will foster wonder, debate, and in some cases consternation. Above all, though, they need to be understood by those who will be most affected - all of us.